Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

HeartSine Technologies Ltd

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

HeartSine Technologies Ltd

Regulatory records
9
Linked recall entries
4
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 9 FDA records to the applicant name HeartSine Technologies Ltd. 4 entries are PMA supplements. 5 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Aug 27, 2025 to Jun 22, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code MKJ appears in 9 of the 9 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P160008, with 9 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.

Applicant mailing address recorded by FDA: 207 Airport Rd. W., Belfast, BT3 9ED. Recorded on P160008/S035, decision dated Jun 22, 2026.

Changes described in PMA records

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

RECALL COVERAGE

Recalls linked to this firm

MedtechLedger links 4 FDA enforcement entries through the recorded recalling firm or an exact submission number published in FDA’s recall data. 3 Class II, 1 Class III records are represented. Each row is an enforcement entry; one recall event can cover several product entries. These counts describe this collection and do not measure a manufacturer’s safety record or an injury rate.

Recall / productCompanyClassificationReport dateSource
HeartSine Technologies LtdClass IIIOct 7, 2026FDA
HeartSine Technologies LtdClass IISep 16, 2026FDA
HeartSine Technologies LtdClass IIOct 29, 2025FDA
HeartSine Technologies LtdClass IIAug 6, 2025FDA

Connections use the recorded recalling firm or the submission identifiers shown below. A shared submission connects the records; it does not establish that differently named legal applicants are interchangeable. Use the exact affected models, lots and instructions on each notice.

Source information

Source updated Nov 11, 2026. Retrieved Nov 20, 2026.

Regulatory record history

Product / regulatory recordCompanyPathwayDecision dateSource
HeartSine Technologies LtdPMA supplementJun 22, 2026FDA
HeartSine Technologies LtdPMA supplementMay 18, 2026FDA
HeartSine Technologies LtdPMA supplementMay 7, 2026FDA
HeartSine Technologies LtdPMA supplementJan 8, 2026FDA
HeartSine Technologies LtdPMA supplementDec 22, 2025FDA
HeartSine Technologies LtdPMA supplementSep 29, 2025FDA
HeartSine Technologies LtdPMA supplementSep 17, 2025FDA
HeartSine Technologies LtdPMA supplementSep 2, 2025FDA
HeartSine Technologies LtdPMA supplementAug 27, 2025FDA
Source information

Source updated Nov 9, 2026. Retrieved Nov 20, 2026.